NCT00238446已完成3 期
A Prospective, Open-label, Multicenter Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Heart Transplant Recipients
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
研究概览
简要总结
This purpose of this extension study of patients being treated with EC-MPS is to assess the long term safety of this medication.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who were participating in the core study CERL080A2401 and have successfully completed the first 12 months of the core study
排除标准
- •Patients who did not complete the 12-month core study CERL080A2401
- •Other protocol-defined inclusion/exclusion criteria may apply.
研究者
相似试验
已完成
3 期
Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant RecipientsRenal TransplantationNCT00239070Novartis69
已完成
3 期
Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney TransplantsRenal TransplantationNCT00238940Novartis55
已完成
4 期
Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate MofetilRenal TransplantationNCT00238966Novartis187
已完成
4 期
Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant RecipientsDe Novo Kidney Transplant RecipientsNCT00312143Novartis35
Unknown
不适用
Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)Crohn's DiseaseNCT02926300Kang Stem Biotech Co., Ltd.24